News from the Heart Rhythm Society2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Keywords
Abbreviations
Cited by (0)
Document Reviewers: Carina Blomström-Lundqvist, MD, PhD; Angelo A.V. De Paola, MD, PhD; Peter M. Kistler, MBBS, PhD; Gregory Y.H. Lip, MD; Nicholas S. Peters, MD; Cristiano F. Pisani, MD; Antonio Raviele, MD; Eduardo B. Saad, MD, PhD; Kazuhiro Satomi, MD, PhD; Martin K. Stiles, MB ChB, PhD; Stephan Willems, MD, PhD
Developed in partnership with and endorsed by the European Heart Rhythm Association (EHRA), the European Cardiac Arrhythmia Society (ECAS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Society of Cardiac Stimulation and Electrophysiology (Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología [SOLAECE]).
Developed in collaboration with and endorsed by the Society of Thoracic Surgeons (STS), the American College of Cardiology (ACC), the American Heart Association (AHA), the Canadian Heart Rhythm Society (CHRS), the Japanese Heart Rhythm Society (JHRS), and the Brazilian Society of Cardiac Arrhythmias (Sociedade Brasileira de Arritmias Cardíacas [SOBRAC]).
Chair: Hugh Calkins, MD, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Section Chairs:
Definitions, Mechanisms, and Rationale for AF Ablation: Shih-Ann Chen, MD, National Yang-Ming University, Taipei, Taiwan.
Modifiable Risk Factors for AF and Impact on Ablation: Jonathan M. Kalman, MBBS, PhD, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia.
Indications: Claudio Tondo, MD, PhD, Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy.
Strategies, Techniques, and Endpoints: Karl Heinz Kuck, MD, PhD, Asklepios Klinik St. Georg, Hamburg, Germany.
Technology and Tools: Andrea Natale, MD, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.
Technical Aspects of Ablation to Maximize Safety and Anticoagulation: David E. Haines, MD, Beaumont Health System, Royal Oak, MI, USA.
Follow-up Considerations: Francis E. Marchlinski, MD, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Outcomes and Efficacy: Matthew R. Reynolds, MD, MSc, Lahey Hospital and Medical Center, Burlington, MA, USA.
Complications: D. Wyn Davies, MD, Imperial College Healthcare NHS Trust, London, United Kingdom.
Training Requirements: Bruce D. Lindsay, MD, Cleveland Clinic, Cleveland, OH, USA.
Surgical and Hybrid AF Ablation: James R. Edgerton, MD, The Heart Hospital, Baylor Plano, Plano, TX, USA.
Clinical Trial Design: Atul Verma, MD, Southlake Regional Health Centre, University of Toronto, Toronto, Canada.
Correspondence: Heart Rhythm Society, 1325 G Street NW, Suite 400, Washington, DC 20005. E-mail address: [email protected].
- ∗
Representative of the European Heart Rhythm Association (EHRA)
- †
Representative of the American Heart Association (AHA)
- ‡
Representative of the Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)
- §
Representative of the Asia Pacific Heart Rhythm Society (APHRS)
- ‖
Representative of the American College of Cardiology (ACC)
- ¶
Representative of the European Cardiac Arrhythmia Society (ECAS)
- #
Representative of the Society of Thoracic Surgeons (STS)
- ∗∗
Representative of the Canadian Heart Rhythm Society (CHRS)
- ††
Representative of the Japanese Heart Rhythm Society (JHRS)
- ‡‡
Representative of the Sociedade Brasileira de Arritmias Cardíacas (SOBRAC)